Perhaps because the disclosed payment was relatively small, or that the acquisition was overshadowed by other news out of Juno Therapeutics over the previous week, the Seattle biotech’s purchase of a small firm founded by a Northeastern University professor last week wasn’t widely covered.
In an interview, the professor who founded RedoxTherapies — Michail “Misha” Sitkovsky, professor of immunophysiology and the director of New England Inflammation and Tissue Protection Institute — contended…
Perhaps because the disclosed payment was relatively small, or that the acquisition was overshadowed by other news out of Juno Therapeutics over the previous week, the Seattle biotech’s purchase of a small firm founded by a Northeastern University professor last week wasn’t widely covered.
In an interview, the professor who founded RedoxTherapies — Michail “Misha” Sitkovsky, professor of immunophysiology and the director of New England Inflammation and Tissue Protection Institute — contended…